Search Results: PARP inhibitor

• Health & Medicine

Targeted ovarian cancer drug made available to more people on NHS in England

NICE has made olaparib (Lynparza), a targeted cancer drug, more widely available for people with ovarian cancer on the NHS in England. NICE has made olaparib (Lynparza), a targeted cancer drug, more widely available for people with ovarian cancer on the NHS in England.

11 December 2019

• Health & Medicine

Advanced ovarian cancer treatment approved for Cancer Drugs Fund

A targeted treatment for advanced ovarian cancer has been approved for use on the NHS in England and will be paid for by the Cancer Drugs Fund. A targeted treatment for advanced ovarian cancer has been approved for use on the NHS in England and will be paid for by the Cancer Drugs Fund.

11 October 2019

• Health & Medicine

Advanced ovarian cancer drug gets initial ‘no’ for NHS in England

A targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England. A targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England.

9 August 2019

• Health & Medicine

Targeted drug trial points to potential ‘new age’ for pancreatic cancer treatment

A drug that’s designed to target weaknesses inside cancer cells can hold some advanced pancreatic cancers at bay for a short time after chemotherapy. A drug that’s designed to target weaknesses inside cancer cells can hold some advanced pancreatic cancers at bay for a short time after chemotherapy.

2 June 2019

• For Researchers

Promoting an academic culture of entrepreneurship at our first Innovation Summit

Our Innovation Summit and Innovation Prizes are creating new opportunities to develop the translational and commercial potential of your breakthrough science. Our Innovation Summit and Innovation Prizes are creating new opportunities to develop the translational and commercial potential of your breakthrough science.

1 April 2019

• Science & Technology

International Women’s Day: a Wikipedia edit-a-thon for women in cancer research 

Less than 1 in 5 Wikipedia biographies are about women. We wanted to change that. Less than 1 in 5 Wikipedia biographies are about women. We wanted to change that.

8 March 2019

• For Researchers

Celebrating a lifetime in cancer biology, an early diagnosis champion, and our leaders of tomorrow: the 2018 CRUK Research Prizes

We've awarded our annual research prizes at the NCRI Conference in Glasgow. Find out who won our Future Leaders, Jane Wardle, and Lifetime Achievement prizes. We've awarded our annual research prizes at the NCRI Conference in Glasgow. Find out who won our Future Leaders, Jane Wardle, and Lifetime Achievement prizes.

19 December 2018

• Health & Medicine

Targeted drug could slow progression of ovarian cancer in women with faulty BRCA gene

A drug could help slow the progression of some advanced ovarian cancers and extend the time that patients show no signs of disease, according to new research. A drug could help slow the progression of some advanced ovarian cancers and extend the time that patients show no signs of disease, according to new research.

24 October 2018

• Science & Technology
• Health & Medicine

Scientists exploit leaks in blood brain barrier to treat glioblastoma

An ovarian cancer drug can leak through the blood brain barrier to reach brain tumours and could be an effective treatment for glioblastoma. An ovarian cancer drug can leak through the blood brain barrier to reach brain tumours and could be an effective treatment for glioblastoma.

6 November 2017

• Science & Technology
• Health & Medicine

News digest – Brexit, viral treatments, alcohol, and… prostate cancer screening?

In this week's cancer news there's Brexit plans, viruses being used as treatments, and disagreements over screening for prostate cancer. In this week's cancer news there's Brexit plans, viruses being used as treatments, and disagreements over screening for prostate cancer.

9 September 2017